| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.0009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |